Viewing Study NCT07123350


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-04-19 @ 5:56 AM
Study NCT ID: NCT07123350
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Sponsor: Vanderbilt University Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module